Earnings ·
SI-BONE, Inc. reported financial results for the quarter ended June 30, 2026, announcing worldwide revenue of $56.0…
SIBNSI-BONE, Inc.
SI-BONE, Inc. reported financial results for the quarter ended June 30, 2026, announcing worldwide revenue of $56.0 million, a 15.2% increase year-over-year. The company achieved positive adjusted EBITDA of $2.8 million and a net loss of $4.1 million, an improvement of 33.6%. SI-BONE raised its full-year 2026 revenue guidance to $231–$233 million, implying ~15-16% growth, while maintaining gross margin guidance at ~79%. The U.S. physician base grew 19% to 1,715 active physicians, and the company submitted a 510(k) application for a new breakthrough device in June. SI-BONE operates in the medical technology industry, developing procedural solutions for compromised bone.